Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Value-Based Contracts: Relief From Regulatory Barriers In Sight?

Executive Summary

Novartis CEO Jimenez suggests Trump Administration may help remove regulatory barriers to US outcome-based contracting between manufacturers and payers; Duke Margolis Center for Health Policy plans policy initiative to promote value-based purchasing for drugs, medical devices and gene therapy.


Related Content

Amgen's Ofman On Value-Based Contracts And Reimbursement Challenges
Best Of BIO: Policy & Regulatory Updates From BIO 2017
BIO Notebook, Day 1: Janssen, Boehringer And More Talk Deals, Pipeline Progress And Investment
Trump Drug Pricing Plan May Include Rebate Pass-Through Push – Novartis CEO
Patient Voice Needed In Outcomes-Based Contracts, PhRMA Exec Says
US FDA’s Bipartisan Support May Offer Shelter From Political Winds, Former Chief Says
Carrots and Stick: Biopharma At The White House
US Outcomes-Based Contracts: Big Uptick In Interest, But Not Execution
Duke's McClellan: Changing Drug Development Policy From Outside FDA
Lilly, Anthem Singing Same Tune On Value-Based Pricing, Communication Policy


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts